1st Quarter - Amendment
OSIRIS THERAPEUTICS for OSIRIS THERAPEUTICS
Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Amendment | Apr 20, 2015 | — | Replaced |
| 1st Quarter - Amendment (this page) | Jul 23, 2015 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to reimbursement policy for Medicare products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA KATHLEEN DIXON | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FRIEDI CORPORATION FINANCE AG | Switzerland | Switzerland | 39.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.